SCHEMBL6164740

SCHEMBL6164740

NC(Cc1ccccc1)C(=O)NC1CCSc2ccccc21

nearest known ligand 0.55

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
ALPL P05186 1/20 0.55
ALPI P09923 1/20 0.55
NPC1 O15118 2/20 0.50
KMT2A Q03164 2/20 0.48
MEN1 O00255 1/20 0.48
SIRT5 Q9NXA8 2/20 0.48
TDP1 Q9NUW8 1/20 0.47
USP2 O75604 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29131632 0.81 OPRK1 (0.59) KMT2AMEN1
SCHEMBL29131630 0.81 OPRK1 (0.59) KMT2AMEN1
SCHEMBL14521552 0.78 KMT2A (0.60) NPC1KMT2AMEN1TDP1USP2
SCHEMBL8198399 0.78 NPC1 (0.55) ALPLALPINPC1KMT2AMEN1
SCHEMBL19962665 0.76 OPRK1 (0.66)
SCHEMBL19962526 0.76 OPRK1 (0.66)
SCHEMBL14277889 0.76 POLB (0.64) ALPLALPINPC1KMT2AMEN1
SCHEMBL19969752 0.75 OPRK1 (0.75)
SCHEMBL5651521 0.74 TAOK3 (0.58) KMT2AMEN1
SCHEMBL6166506 0.73 TDP1 (0.61) ALPITDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1134213-B1 Process for the preparation of substituted N-(indole-2-carbonyl)- glycinamides PFIZER (US) 2005-11-02 EP disclosed
EP-0832065-B1 SUBSTITUTED N-(INDOLE-2-CARBONYL)-GLYCINAMIDES AND DERIVATIVES AS GLYCOGEN PHOSPHORYLASE INHIBITORS PFIZER (US) 2001-10-10 EP disclosed
EP-1134213-A2 Process for the preparation of substituted N-(indole-2-carbonyl)- glycinamides PFIZER INC. (US) 2001-09-19 EP disclosed
US-6277877-B1 GLYCOGEN PHOSPHORYLASE INHIBITOR; ANTIDIABETIC AGENTS PFIZER, INC. 2001-08-21 US disclosed
US-6107329-A HYPOTENSIVE AGENTS; CARDIOVASCULAR DISORDERS PFIZER, INC. (US) 2000-08-22 US disclosed